The relationship between the location of the breakpoint within the M-bcr and clinical parameters.
The Philadelphia chromosome (t9;22)(q34;q11) is a characteristic abnormality in chronic myeloid leukemia. In greater than 95% of the cases, the breakpoint occurs with the M-bcr region of the BCR gene on chromosome 22. Several studies have attempted to correlate the location of the breakpoint within the M-bcr with a clinical parameter. The majority of studies have examined the relationship between the site of breakpoint and the median chronic phase duration (CPD). Some studies have reported a correlation, with 5' breakpoint patients who have a longer median CPD than patients with a 3' breakpoint. However, other groups have reported that no correlation exists. Furthermore, data from some of the latter groups have suggested that a correlation may exist with the lineage of blast crisis which developed and 3' breakpoint patients had a higher than expected number of lymphoid blast crisis. A correlation between high platelet counts at diagnosis and patients with a 3' breakpoint or those who expressed a b3-a2 BCR-ABL mRNA has also been described. No consistent conclusion from any of these studies can be drawn. This may due, in part, to some degree of patient and sample selection, although environmental, genetic or life-style factors may also contribute.
Mills
K I
KI
Department of Haematology, Glasgow Royal Infirmary, Scotland.
D014408:Biomarkers, Tumor / Q000235:genetics*; D001752:Blast Crisis / Q000145:classification / Q000235:genetics / Q000401:mortality; D002869:Chromosome Aberrations; D015331:Cohort Studies; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D007564:Japan / Q000453:epidemiology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D015466:Leukemia, Myeloid, Chronic-Phase / Q000235:genetics; D008297:Male; D010976:Platelet Count; D011379:Prognosis; D012606:Scotland / Q000453:epidemiology; D016019:Survival Analysis
D014408:Biomarkers, Tumor; D016044:Fusion Proteins, bcr-abl